<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kam</surname>
    <given-names>Y. W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C. Y.</given-names>
   </name>
   <name>
    <surname>Teo</surname>
    <given-names>T. H.</given-names>
   </name>
   <name>
    <surname>Howland</surname>
    <given-names>S. W.</given-names>
   </name>
   <name>
    <surname>Amrun</surname>
    <given-names>S. N.</given-names>
   </name>
   <name>
    <surname>Lum</surname>
    <given-names>F. M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections</article-title>. 
  <source>JCI Insight</source>
  <volume>2</volume>:
  <fpage>8</fpage>. 
  <pub-id pub-id-type="doi">10.1172/jci.insight.92428</pub-id>
  <?supplied-pmid 28422757?>
  <pub-id pub-id-type="pmid">28422757</pub-id>
 </mixed-citation>
</ref>
